Walmart stock slips despite earnings beat – What’s weighing down retailers?

Walmart’s stock, along with shares of other major retailers, tumbled in early Thursday trading after the retail giant issued a weaker-than-expected forecast for the year ahead.

Despite meeting expectations with its fourth-quarter results, Walmart’s outlook for fiscal 2026 disappointed investors. Revenue for the quarter ending Jan. 31 climbed 4.1% year over year to $180.6 billion, slightly exceeding analysts’ expectations of $180 billion, according to FactSet. Adjusted earnings per share came in at 66 cents, just above the forecasted 65 cents. Additionally, the company announced a 13% increase in its dividend to 94 cents per share—the largest boost in over a decade.

CEO Doug McMillon highlighted the company’s strong momentum, citing low prices, an expanding product assortment, and a fast-growing eCommerce business. “We’re gaining market share, our top line is healthy, and we’re in great shape with inventory,” he said in the earnings release.

However, Walmart’s shares dropped about 8% to $95.72 before the opening bell as its full-year guidance failed to impress. The company expects net sales growth of 3% to 4%, falling short of analysts’ estimates of roughly 4%. It also projected adjusted earnings per share between $2.50 and $2.60 for the year, with the $2.55 midpoint significantly below Wall Street’s $2.77 estimate.

The disappointing forecast weighed on the broader retail sector. The SPDR S&P Retail ETF slipped 1%, while futures tracking the S&P 500 dipped 0.3%. Target shares fell 2.4%, Home Depot 0.4%, Costco Wholesale 1.6%, and Amazon.com 0.7%.

First-quarter guidance also came in under expectations, with Walmart predicting adjusted earnings per share between 57 cents and 58 cents—lower than analysts’ anticipated 64 cents. The company attributed its conservative forecast to a “generally stable consumer” and ongoing pressure from its global product and format mix. A Walmart spokeswoman described the guidance as a “prudent” start to the year.

The stock’s sharp drop wasn’t entirely unexpected. Walmart was one of the top performers in the Dow Jones Industrial Average in 2024 and has consistently traded above its 50-day moving average for more than a year, according to Jay Woods, chief global strategist at Freedom Capital Markets. Entering earnings season, Walmart shares traded at 37.3 times next year’s earnings—just shy of their five-year high of 37.9 times. The stock had climbed 15% this year and nearly 80% over the past 12 months.

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth